The Multiple Sclerosis Treatment Optimization Program.

Annette M Langer-GouldStephen C ChengBonnie H LiMichael H Kanter

Published in: Annals of clinical and translational neurology (2021)

The causes of wasteful spending on MS DMTs are complex and require multiple strategies to resolve. We provide herein granular details of how we designed and implemented our health system intervention to facilitate its adaption to other settings and conditions.

Keyphrases

multiple sclerosis
randomized controlled trial
white matter
quality improvement
ms ms
combination therapy